Eden Research set for debut on May 11th

Eden Research, an agrochemical and encapsulation development company, is all set to start trading on AIM on May 11th.

Zeus Capital Limited is acting as nominated adviser (nomad) and broker in relation to the admission to AIM and the market capitalisation of the company at admission is expected to be in the region of £20.54m.

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

The company is developing these technologies through research and a series of commercial production, marketing and distribution partnerships.

The ticker symbol for the company will be EDEN.

JH